A disease-modifying effect of GDF-15 is further supported by findings that a polymorphism in the GDF15 gene (H6D) affects both tumor risk and prognosis in colorectal (113, 128) and in prostate cancer (HR: 0.83 or 0.85 from two different studies) (129, 130). This evidence concerns the gene GDF15 and prostate carcinoma.